Toronto Stocks Flat; Laurentian Bank of Canada Declines on Lower 4Q Profit, Revenue
By Adriano Marchese
Toronto stocks were flat at midday on Thursday as investors digest the Bank of Canada's decision to hold interest rates at 5% on Wednesday. Sector performance was mixed, with technology up the most followed by commercial services. Health services was the main laggard.
Canada's S&P/TSX Composite Index edged up 0.03% to 20280.88. The blue-chip S&P/TSX 60 was down 0.06% to 1222.63.
Shares of Laurentian Bank of Canada, which focuses primarily on the Quebec market, fell by 1.6% to 25.98 Canadian dollars ($19.11) after it reported lower profit and revenue in the fourth quarter, in part due to one-off costs and charges.
Other market movers:
ADF Group's shares gained 17% to C$5.25 after the steel products maker reported higher profit and revenue in the third quarter.
Shares of Willow Biosciences climbed 35% to C$0.14 after the Toronto-listed biotechnology company said it will continue to work toward commercialization of its BioOxi platform with its partner after a positive preliminary feasibility program.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
December 07, 2023 12:32 ET (17:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?